Announcements Trials
Browse Landscape

Status

Completed 6

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 58Observational 6

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Lymphoma 2Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Observational × plerixafor × Clear all
NCT03406091 2024-02-20

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Fondazione EMN Italy Onlus

Completed
300 enrolled
Plasma cell

Multiple Myeloma

NCT00741780 2015-03-24

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

Sanofi

Completed
164 enrolled
Plasma cell

Multiple Myeloma

NCT01738373 2015-03-23

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Sanofi

Completed
262 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT01141543 2014-07-18

Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection

University Health Network, Toronto

Completed
12 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00741325 2014-02-11

Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).

Sanofi

Completed
178 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT01700608 2012-10-04

Prospective Observational Study on Plerixafor After Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
27 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡